drugset / Trial / NCT01367561

Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function

NCT01367561

Phase 1 Completed 15 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a double-blind, randomized, study at a single clinical site investigating the effect of methylnaltrexone and naloxone versus placebo in healthy males who have received a short-acting opioid, remifentanil.

Timeline

Start
2002-10
Primary completion
2003-05
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified Intravenous
Subject Naloxone Small molecule

Indications

No indication recorded.